Wei Kangkang, Li Jinming, Yu Lintong, Chen Li, Gao Jie, Zhu Chunlin, Liu Min, Li Min, Shi Dazhuo, Ma Xiaojuan
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
Shandong Provincial Third Hospital, Jinan, 250031, China.
J Ethnopharmacol. 2025 Sep 5;354:120549. doi: 10.1016/j.jep.2025.120549.
Both chuanxiong rhizome and Coptis chinensis were first recorded in the Shennong's Classic of Materia Medica. Chuanxiong rhizome and Coptis chinensis are a classic herbal pair in Traditional Chinese Medicine (TCM), renowned for their effects in activating blood circulation and resolving toxicity. They are widely used to treat chest impediment and heart pain.Tetramethylpyrazine (TMP) and berberine (BBR) are the main active components isolated from Chuanxiong Rhizome and Coptis chinensis, respectively. Both components have been applied to the treatment of various cardiovascular diseases owing to their anti-platelet, anti-inflammatory, and endothelial-protective effects. It has been demonstrated that the combination of TMP with BBR produces more effective anti-thrombotic effects compared with the monotherapy based on either agent.
This study was designed to explore the potential role and mechanisms of TMP combined with BBR in reducing the formation of coronary microembolization (CME) in rats.
CME was induced by the injection of sodium laurate into the left ventricular of rats. CME formation and myocardial damage were examined using histopathology, while echocardiography was used to assess cardiac functions. Additionally, a series of in vitro experiments was performed to examine how platelet-derived exosomes (PLT-exo) enriched with miR-34a-5p influence human umbilical vein endothelial cells (HUVECs) subjected to ox-LDL and macrophages stimulated with LPS.Moreover, TMP and BBR were added to observe their effects.
The combination of TMP and BBR significantly mitigated CME formation, myocardial injury, and left ventricular ejection fraction (LVEF) in rats. Besides, the pretreatment with TMP and BBR inhibited platelet activation, alleviated endothelial cell damage, and reduced the number of M1 macrophages. Additionally, the levels of miR-34a-5p in PLT-exo of CME rats were suppressed after the pretreatment with TMP and BBR. However, these effects of TMP and BBR were attenuated after the injection of agomiR-34a-5p in CME rats. Furthermore, TMP combined with BBR ameliorated in vitro HUVEC damage and M1-type macrophage polarization induced by an increase in miR-34a-5p in PLT-exo.
Our study concluded that the combination of TMP and BBR prevented CME and improved cardiac functions in rats by suppressing miR-34a-5p in PLT-exo.
川芎和黄连均最早记载于《神农本草经》。川芎和黄连是中药中的经典药对,以活血化瘀、解毒功效著称,广泛用于治疗胸痹和心痛。川芎嗪(TMP)和小檗碱(BBR)分别是从川芎和黄连中分离出的主要活性成分。这两种成分因其抗血小板、抗炎和内皮保护作用,已被应用于多种心血管疾病的治疗。已证明,与单一药物治疗相比,TMP与BBR联合使用具有更有效的抗血栓形成作用。
本研究旨在探讨TMP联合BBR在减少大鼠冠状动脉微栓塞(CME)形成中的潜在作用及机制。
通过向大鼠左心室注射月桂酸钠诱导CME。采用组织病理学检查CME形成和心肌损伤,同时用超声心动图评估心脏功能。此外,进行了一系列体外实验,以研究富含miR-34a-5p的血小板衍生外泌体(PLT-exo)如何影响经氧化型低密度脂蛋白(ox-LDL)处理的人脐静脉内皮细胞(HUVECs)以及经脂多糖(LPS)刺激的巨噬细胞。此外,加入TMP和BBR观察其作用。
TMP与BBR联合使用可显著减轻大鼠CME形成、心肌损伤和左心室射血分数(LVEF)。此外,TMP和BBR预处理可抑制血小板活化,减轻内皮细胞损伤,减少M1巨噬细胞数量。此外,TMP和BBR预处理后,CME大鼠PLT-exo中miR-34a-5p水平受到抑制。然而,在CME大鼠中注射agomiR-34a-5p后,TMP和BBR的这些作用减弱。此外,TMP联合BBR改善了体外PLT-exo中miR-34a-5p增加所诱导的HUVEC损伤和M1型巨噬细胞极化。
我们的研究得出结论,TMP与BBR联合使用可通过抑制PLT-exo中的miR-34a-5p预防大鼠CME并改善心脏功能。